TP53 and breast carcinoma: Moreover, patients with premenopausal (Figure6B, P = 0.155), estrogen receptor-negative (Figure6F, P = 0.170) and p53-negative (Figure6I, P = 0.089) breast cancer showed a trend for poor overall survival, although this was not statistically significant.